COMPLE B (9.532 + 1.049 + 3.039 + 12.5) MG/COM COM REV CT FR PLAS OPC X 50
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1384100510227 -
GGREM
540420110015007 -
Código de barras
7898133137549
O que a fonte publica
- Detentor do registro
- NATULAB LABORATORIO S.A
- Princípios ativos
- NICOTINAMIDA;FOSFATO DE RIBOFLAVINA;CLORIDRATO DE PIRIDOXINA;CLORIDRATO DE TIAMINA
- Embalagem
- (9.532 + 1.049 + 3.039 + 12.5) MG/COM COM REV CT FR PLAS OPC X 50
- Tipo de produto
- Específico
- Classe terapêutica
- A11E1 - COMPLEXO B PURO
Nomes pelos quais este registro é encontrado
- COMPLE B (9.532 + 1.049 + 3.039 + 12.5) MG/COM COM REV CT FR PLAS OPC X 50
- COMPLE B
- NICOTINAMIDA
- FOSFATO DE RIBOFLAVINA
- CLORIDRATO DE PIRIDOXINA
- CLORIDRATO DE TIAMINA
Dados completos da fonte
{
"name": "COMPLE B (9.532 + 1.049 + 3.039 + 12.5) MG/COM COM REV CT FR PLAS OPC X 50",
"holder": "NATULAB LABORATORIO S.A",
"stripe": null,
"barcodes": [
"7898133137549"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "540420110015007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "02.456.955/0001-83",
"priceRegime": "Liberado",
"productName": "COMPLE B",
"productType": "Específico",
"hospitalOnly": false,
"presentation": "(9.532 + 1.049 + 3.039 + 12.5) MG/COM COM REV CT FR PLAS OPC X 50",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "25.41",
"icms-12": "28.88",
"icms-17": "30.61",
"icms-18": "30.99",
"icms-19": "31.37",
"icms-20": "31.76",
"icms-21": "32.16",
"icms-22": "32.58",
"icms-23": "33.00",
"icms-17.5": "30.80",
"icms-19.5": "31.57",
"icms-20.5": "31.96",
"icms-22.5": "32.79",
"icms-12-alc": "25.78",
"icms-17-alc": "27.33",
"icms-18-alc": "27.67",
"icms-19-alc": "28.01",
"icms-20-alc": "28.36",
"icms-21-alc": "28.72",
"icms-22-alc": "29.09",
"icms-23-alc": "29.46",
"withoutTaxes": "22.69",
"icms-17.5-alc": "27.50",
"icms-19.5-alc": "28.18",
"icms-20.5-alc": "28.54",
"icms-22.5-alc": "29.27"
},
"pisCofinsList": "Negativa",
"substanceText": "NICOTINAMIDA;FOSFATO DE RIBOFLAVINA;CLORIDRATO DE PIRIDOXINA;CLORIDRATO DE TIAMINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "34.09",
"icms-12": "38.74",
"icms-17": "41.06",
"icms-18": "41.57",
"icms-19": "42.08",
"icms-20": "42.60",
"icms-21": "43.14",
"icms-22": "43.70",
"icms-23": "44.27",
"icms-17.5": "41.32",
"icms-19.5": "42.35",
"icms-20.5": "42.87",
"icms-22.5": "43.99",
"icms-12-alc": "35.64",
"icms-17-alc": "37.78",
"icms-18-alc": "38.25",
"icms-19-alc": "38.72",
"icms-20-alc": "39.21",
"icms-21-alc": "39.70",
"icms-22-alc": "40.22",
"icms-23-alc": "40.73",
"withoutTaxes": "31.36",
"icms-17.5-alc": "38.02",
"icms-19.5-alc": "38.96",
"icms-20.5-alc": "39.45",
"icms-22.5-alc": "40.46"
},
"invalidBarcodes": [],
"activeSubstances": [
"NICOTINAMIDA",
"FOSFATO DE RIBOFLAVINA",
"CLORIDRATO DE PIRIDOXINA",
"CLORIDRATO DE TIAMINA"
],
"therapeuticClass": "A11E1 - COMPLEXO B PURO",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1384100510227",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "A11E1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:540420110015007"